Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000893220-96-001364
Filing Date
1996-08-13
Accepted
1996-08-13 00:00:00
Documents
4
Period of Report
1996-06-30
SROs
NONE

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q HEMISPHERX BIOPHARMA, INC. 10-Q 34431
2 COMPUTATION OF NET LOSS PER SHARE 3 MONTHS EX-11 2415
3 COMPUTATION OF NET LOSS PER SHARE 6 MONTHS EX-12 2419
4 FINANCIAL DATA SCHEDULE EX-27 2057
  Complete submission text file 0000893220-96-001364.txt   43177
Mailing Address 1617 JFK BLVD ONE PENN CENTER PHILADELPHIA PA 19103
Business Address 1617 JFK BLVD ONE PENN CENTER PHILADELPHIA PA 19103 2159880080
HEMISPHERX BIOPHARMA INC (Filer) CIK: 0000946644 (see all company filings)

EIN.: 520845822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-27072 | Film No.: 96611425
SIC: 5122 Wholesale-Drugs, Proprietaries & Druggists' Sundries